XienceV stent vs Cypher stent in primary PCI for acute myocardial infarction.
Recruiting
- Conditions
- 1. Acute myocardial infarction<br />2. drug-eluting stent.
- Registration Number
- NL-OMON27542
- Lead Sponsor
- Dr. S.H. HofmaMedisch centrum Leeuwardencardiologie poli 67Henri Dunantweg 28934 AD LeeuwardenThe Netherlandsshhofma@hetnet.nl+31-58 2867766
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 800
Inclusion Criteria
1. Patients with acute ST elevated myocardial infarction;
2. Patient is willing to perform all follow-up examination as required by the protocol;
Exclusion Criteria
1. Chronical total occlusion as target lesion intervention;
2. stent thrombosis or previous stent at target lesion;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical MACE at 1 year (cardiac mortality, non-fatal myocardial infarction, TVR.
- Secondary Outcome Measures
Name Time Method 1. (Sub)-acute stent thrombosis (SAT) at 30 days and late stent thrombosis (LST) at 1, 2 and 3 year;<br /><br>2. Clinical MACE at 30 days and 2 and 3 year (cardiac death, non fatal MI, TVR);<br /><br>3. All cause mortality at 1,2 and 3 year.